Purple Medical Solution Pvt ltd.
About us
With years of experience in medical device market, the founders solicited representations from Canadian based MIV Therapeutics Inc for bringing cutting edge technology and innovative devices.
Purple Medical Solutions Pvt. Ltd. ("Purple") was incorporated in year 2007 as a Marketing Company with the intention and purpose of getting into the manufacturing space and be in the fore front of the cardiovascular device field.
In India, Purple introduced and launched MIV products and within a span of 5 years, it became the one of the largest Coronary Stent Company in India with more than 28000 deployments in just last 3 years.
With a motto of “In Touch with Tomorrow”, we have always aimed to become a leader as a marketing organization in the field of medical devices. Purple has been focusing on patients' care and developing innovative solutions. Close collaboration with expert physicians and researchers characterize the company. This approach considerably accelerates the development of an idea into a marketable product.
A world class manufacturing plant has been established in Gujarat, India. An ISO 9001, 13485 & cGMP certified ultra-modern facility brag over 11,000 sq. ft. of Class 10,000(ISO 7) & Class 1,00,000 (ISO 8) clean room. All key activities are performed under Class 100 LAF.
Unique manufacturing layout ensures flawless man-material movement to eliminate production errors. All processes are conducted in-house for manufacturing of vascular stents and accessories along with sterilization, analytical and microbiological QA/QC tests.
The core team management members of Purple were working with multinational pharmaceutical companies and leading Indian medical device companies in the past and possess rich experience in the medical field. A strong experienced team of 70 personnel comprises of – Designers, Engineers, R&D Scientists, Chemists, Microbiologists, Regulatory & Clinical Affair experts, Legal, Admin and Finance, Sales and Marketing persons
Through our high quality medical devices, we impact the lives we touch, and we are committed to continue investing in and developing pioneering medical technology, pharmacological research, and engineering newer, safer and effective medical devices that will further benefit our patients. This will create the greatest possible patient outcomes, and provide value to our stakeholders including physicians, shareholders and employees.